These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3390914)

  • 1. Sialic acid in sickle cell disease.
    Ekeke GI; Ibeh GO
    Clin Chem; 1988 Jul; 34(7):1443-6. PubMed ID: 3390914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte sialic acid in human sickle-cell disease.
    Onyemelukwe GC; Esievo KA; Kwanashie CN; Kulkarni AG; Obinechie EN
    J Comp Pathol; 1987 Mar; 97(2):143-7. PubMed ID: 3597847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP; Diloy-Puray M; Streczyn M
    Biochim Biophys Acta; 1979 Oct; 557(1):149-55. PubMed ID: 549632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid content of erythrocytes in normal individuals and patients with certain hematologic disorders.
    Aminoff D; Anderson J; Dabich L; Gathmann WD
    Am J Hematol; 1980; 9(4):381-9. PubMed ID: 7211833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon compounds: effects on the rheological properties of sickle erythrocytes in vitro.
    Reindorf CA; Kurantsin-Mills J; Allotey JB; Castro O
    Am J Hematol; 1985 Jul; 19(3):229-36. PubMed ID: 4014223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antisickling role of uric acid in sickle cell disease.
    Ekeke GI; Nduka N
    Trop Geogr Med; 1987 Apr; 39(2):152-6. PubMed ID: 3629708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.
    Kenny MW; Stuart J
    Br J Haematol; 1983 Nov; 55(3):465-71. PubMed ID: 6639888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickling-induced binding of immunoglobulin to sickle erythrocytes.
    Green GA; Kalra VK
    Blood; 1988 Mar; 71(3):636-9. PubMed ID: 3278749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-sickling activities of two isolated compounds from the root of Combretum racemosum P. beauv. (Combretaceae).
    Famojuro TI; Adeyemi AA; Ajayi TO; Fasola FA; Fukushi Y; Omotade OO; Moody JO
    J Ethnopharmacol; 2021 Jun; 273():113992. PubMed ID: 33677007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of phosphatidylserine-phosphatidylcholine liposomes with sickle erythrocytes. Evidence for altered membrane surface properties.
    Schwartz RS; Düzgünes N; Chiu DT; Lubin B
    J Clin Invest; 1983 Jun; 71(6):1570-80. PubMed ID: 6408122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.
    Hebbel RP; Yamada O; Moldow CF; Jacob HS; White JG; Eaton JW
    J Clin Invest; 1980 Jan; 65(1):154-60. PubMed ID: 7350195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of the masking effect of sialic acid groups on sialidase-treated erythrocytes by the action of sialyltransferases.
    Kelm S; Shukla AK; Paulson JC; Schauer R
    Carbohydr Res; 1986 Jun; 149(1):59-64. PubMed ID: 3089604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickling and Vinblastine.
    Ricci G; Zavagli G
    Biomed Pharmacother; 1983; 37(2):85-7. PubMed ID: 6616035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-associated sialic acid is an immunological adjuvant.
    van Dijk H; Rademaker PM; Klerx JP; Snippe H; Willers JM
    Immunol Lett; 1985; 11(5-6):337-42. PubMed ID: 4093153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trifluoperazine and membrane-bound sialic acid on 45Ca2+ uptake into erythrocytes.
    Günther T; Höllriegl V; Fehlinger R
    J Trace Elem Electrolytes Health Dis; 1988 Mar; 2(1):15-8. PubMed ID: 2980786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickling-induced binding of autologous IgG to erythrocytes heterozygous for sickle hemoglobin.
    Green GA
    Biochem Med Metab Biol; 1990 Apr; 43(2):105-11. PubMed ID: 2346668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte membrane lipid reorganization during the sickling process.
    Chiu D; Lubin B; Shohet SB
    Br J Haematol; 1979 Feb; 41(2):223-34. PubMed ID: 427032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin.
    Kahane I; Ben-Chetrit E; Shifter A; Rachmilewitz EA
    Biochim Biophys Acta; 1980 Feb; 596(1):10-7. PubMed ID: 7353002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of valinomycin, A23187 and repetitive sickling on irreversible sickle cell formation.
    Westerman MP; Allan D
    Br J Haematol; 1983 Mar; 53(3):399-409. PubMed ID: 6402002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.